Home > Insider Trading > Filing (0000945621-12-000011)

Filing Details

Accession Number:: 0000945621-12-000011
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-01-20 13:45:04
Reporting Period:: 2011-12-23

Filing Date:: 2012-01-20
Accepted Time:: 2012-01-20 13:45:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1344413	Alexza Pharmaceuticals Inc.	ALXA	Pharmaceutical Preparations (2834)	770567768

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1509544	L.p. Fund Master Occitan	Walker House, 87 Mary Street George Town, Grand Cayman E9 KY1-9005		No	No	Yes	Yes
1539739	Occitan Capital Management Inc.	Walker House, 87 Mary Street George Town, Grand Cayman E9 KY1-9005		No	No	Yes	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001	Acquisiton	2012-01-10	100	$0.92	3,644,245	No	4	P	Indirect	See notes
Common Stock, Par Value $0.0001	Acquisiton	2012-01-10	100	$0.92	3,644,345	No	4	P	Indirect	See notes
Common Stock, Par Value $0.0001	Acquisiton	2012-01-10	700	$0.92	3,645,045	No	4	P	Indirect	See notes
Common Stock, Par Value $0.0001	Acquisiton	2012-01-10	500	$0.92	3,645,545	No	4	P	Indirect	See notes
Common Stock, Par Value $0.0001	Acquisiton	2012-01-10	2,500	$0.92	3,648,048	No	4	P	Indirect	See notes
Common Stock, Par Value $0.0001	Acquisiton	2012-01-12	2,441	$0.84	3,650,486	No	4	P	Indirect	See notes
Common Stock, Par Value $0.0001	Acquisiton	2012-01-12	1,000	$0.84	3,651,486	No	4	P	Indirect	See notes
Common Stock, Par Value $0.0001	Acquisiton	2012-01-12	5,000	$0.84	3,656,486	No	4	P	Indirect	See notes
Common Stock, Par Value $0.0001	Acquisiton	2012-01-12	10,000	$0.87	3,666,486	No	4	P	Indirect	See notes
Common Stock, Par Value $0.0001	Acquisiton	2012-01-12	5,000	$0.87	3,671,486	No	4	P	Indirect	See notes
Common Stock, Par Value $0.0001	Acquisiton	2012-01-12	5,000	$0.87	3,676,486	No	4	P	Indirect	See notes
Common Stock, Par Value $0.0001	Acquisiton	2012-01-13	1,900	$0.80	3,678,386	No	4	P	Indirect	See notes
Common Stock, Par Value $0.0001	Acquisiton	2012-01-13	9,800	$0.80	3,688,186	No	4	P	Indirect	See notes
Common Stock, Par Value $0.0001	Acquisiton	2012-01-13	25,000	$0.80	3,713,186	No	4	P	Indirect	See notes
Common Stock, Par Value $0.0001	Acquisiton	2012-01-13	25,000	$0.80	3,738,186	No	4	P	Indirect	See notes
Common Stock, Par Value $0.0001	Acquisiton	2012-01-13	25,000	$0.80	3,763,186	No	4	P	Indirect	See notes
Common Stock, Par Value $0.0001	Acquisiton	2012-01-13	15,000	$0.80	3,778,186	No	4	P	Indirect	See notes
Common Stock, Par Value $0.0001	Acquisiton	2012-01-13	25,000	$0.80	3,803,186	No	4	P	Indirect	See notes
Common Stock, Par Value $0.0001	Acquisiton	2012-01-13	10,000	$0.80	3,813,186	No	4	P	Indirect	See notes
Common Stock, Par Value $0.0001	Acquisiton	2012-01-13	10,000	$0.83	3,823,186	No	4	P	Indirect	See notes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See notes
No	4	P	Indirect	See notes
No	4	P	Indirect	See notes
No	4	P	Indirect	See notes
No	4	P	Indirect	See notes
No	4	P	Indirect	See notes
No	4	P	Indirect	See notes
No	4	P	Indirect	See notes
No	4	P	Indirect	See notes
No	4	P	Indirect	See notes
No	4	P	Indirect	See notes
No	4	P	Indirect	See notes
No	4	P	Indirect	See notes
No	4	P	Indirect	See notes
No	4	P	Indirect	See notes
No	4	P	Indirect	See notes
No	4	P	Indirect	See notes
No	4	P	Indirect	See notes
No	4	P	Indirect	See notes
No	4	P	Indirect	See notes

Footnotes

The securities reported herein are directly beneficially owned by Occitan Master Fund L.P. and may be deemed to be indirectly beneficially owned by Occitan Capital Management Inc. as General Partner of Occitan Master Fund L.P.
Each reporting person listed herein disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.